Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quick Reference: BPC-157 vs TB-500 at a Glance

Amino acid length 15 ~43 (Tβ4); TB-500 is active fragment Approximate MW 1,419 Da ~4,964 Da (full Tβ4) Origin Gastric protein-derived synthetic Endogenous Tβ4 analog Primary mechanism NO modulation, VEGFR2 upregulation G-actin sequestration Strongest model dat

This comparison does not assign a generated winner or score.

  • Amino acid length
  • 15
  • ~43 (Tβ4); TB-500 is active fragment
  • Approximate MW
  • 1,419 Da
  • ~4,964 Da (full Tβ4)
  • Origin
  • Gastric protein-derived synthetic
  • Endogenous Tβ4 analog
  • Primary mechanism
  • NO modulation, VEGFR2 upregulation
  • G-actin sequestration
  • Strongest model data
  • GI, tendon, neurological
  • Cardiac, dermal, corneal
  • Water soluble
  • Yes
  • Lyophilized form
  • FDA approved
  • No
More references

Related material

Comparison

Limitations of This Comparison

Several structural limitations constrain everything above, and honest readers should keep them in view: Species and model gap. The soft-tissue evidence for both compounds is overw…

View details →